Is seel going upbthis afternoon

Seelos Therapeutics Inc. (SEEL) is not expected to experience a significant increase in its stock price this afternoon, based on the following analysis:

1. Recent Performance: SEEL has been experiencing a downward trend, with its stock reaching a 52-week low. In the past year, the company's stock value has plummeted by nearly 99.9%. This indicates a high level of investor skepticism and significant market challenges.
2. Analyst Sentiment: There is no available data on the average price target for SEEL as of September 23, 2024. This lack of analyst coverage or positive price targets could contribute to the stock's downward momentum.
3. Market Conditions: The broader market conditions and industry-specific headwinds have been challenging for SEEL. These factors, combined with the company's financial struggles and the need to reassure investors, suggest that the stock may continue to face downward pressure.
4. Recent Company Developments: SEEL has been actively addressing its financial obligations and corporate governance responsibilities. The appointment of Richard Pascoe as Chairman of the Board of Directors and the modifications to financial agreements, such as the Convertible Promissory Note with Lind Global Asset Management V, LLC, indicate efforts to stabilize the company's financial situation. However, these developments may not have a direct impact on the stock price in the short term.
5. Technical Indicators: The stock's recent price change of $0.14 on September 24, 2024, represents a slight increase from the previous closing price of $0.33. While this is a positive sign, it is not indicative of a trend that would suggest a significant upward movement in the stock price this afternoon.

In conclusion, given the current downward trend, lack of positive analyst sentiment, challenging market conditions, and the recent focus on financial stability rather than stock price appreciation, it is unlikely that SEEL will experience a substantial increase in its stock price this afternoon.